These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 13945458)
1. [Dosage measurement in the environment of patients receiving radiodine therapy]. FLEHMIG RW; MOTZKUS F Strahlentherapie; 1962 Nov; 119():467-73. PubMed ID: 13945458 [No Abstract] [Full Text] [Related]
2. THE METABOLISM OF BIOLOGICALLY IMPORTANT RADIONUCLIDES. V. THE METABOLISM OF RADIOIODINE AND RADIATION DOSAGE IN MAN. HALNAN KE Br J Radiol; 1964 Feb; 37():101-7. PubMed ID: 14120786 [No Abstract] [Full Text] [Related]
3. [RESULTS OF DOSIMETRIC MEASUREMENTS IN THERAPEUTIC WORK WITH RADIOACTIVE IODINE]. SHESHINA GA; RASTARUROV NS; GERASIMIAK VG; PIVANOVA PS Med Radiol (Mosk); 1963 Sep; 8():44-8. PubMed ID: 14094471 [No Abstract] [Full Text] [Related]
4. Some observations on radiation dose to bone marrow during I-131 therapy of thyroid cancer. LEWALLEN CG Am J Roentgenol Radium Ther Nucl Med; 1963 Mar; 89():618-23. PubMed ID: 13930303 [No Abstract] [Full Text] [Related]
5. [RADIOACTIVE IODINE IN THE DIAGNOSIS AND TREATMENT OF CERTAIN THYROID DISEASES]. VERA R Gac Med Caracas; 1964; 72():23-65. PubMed ID: 14183235 [No Abstract] [Full Text] [Related]
6. [ON METHODS FOR THE DETERMINATION OF THE QUANTITY AND FREQUENCY OF I-131 ADMINISTRATION IN THE TREATMENT OF THYROTOXICOSIS]. GARAGASHIAN AA Med Radiol (Mosk); 1964 Aug; 9():18-22. PubMed ID: 14250916 [No Abstract] [Full Text] [Related]
7. [CHANGES IN THE I-131 CONTENT OF THE THYROID GLAND WHEN USED FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES IN PATIENTS WITH THYROTOXICOSIS]. LIVERGANT IuE; CHEBOTAREVA ED Med Radiol (Mosk); 1964 Aug; 9():16-8. PubMed ID: 14250915 [No Abstract] [Full Text] [Related]
8. [Problems of radiometry in endolymphatic therapy using radionuclide]. Pfannenstiel P; Wetzig E; Weissleder H; Strickstrock KH; Kleine N; Hoffman G Strahlentherapie Sonderb; 1969; 69():186-96. PubMed ID: 5778903 [No Abstract] [Full Text] [Related]
9. [STUDIES ON RESPIRATORY ACTIVITY IN PATIENTS FOLLOWING I-131 TREATMENT]. FENYES S; TOPERCZER J Nucl Med (Stuttg); 1963 Oct; 3():280-5. PubMed ID: 14094607 [No Abstract] [Full Text] [Related]
10. [THE CLINICAL USE OF RADIOISOTOPES]. ZIEDSESDESPLANTES BG Ned Tijdschr Geneeskd; 1964 Oct; 108():1982-6. PubMed ID: 14226653 [No Abstract] [Full Text] [Related]
11. [Results of therapy of thyrotoxicosis with radioactive iodine from the viewpoint of complications and dosimetry]. Röhling S; Nĕmec J; Silink K; Vohnout S Cas Lek Cesk; 1969 Jul; 108(35):1043-9. PubMed ID: 5802088 [No Abstract] [Full Text] [Related]
12. RADIOACTIVE ISOTOPES IN CLINICAL MEDICINE. SILVER S N Engl J Med; 1965 Mar; 272():515-22 CONTD. PubMed ID: 14250202 [No Abstract] [Full Text] [Related]
18. THE PROBLEM OF DOSAGE IN THE TREATMENT OF THYROTOXICOSIS BY 131 I. MYANT NB Minerva Nucl; 1964; 8():87-90. PubMed ID: 14152750 [No Abstract] [Full Text] [Related]
19. [Dosimetry in radiation protection]. Minder W Strahlenschutz Forsch Prax; 1970; 10():138-46. PubMed ID: 5522190 [No Abstract] [Full Text] [Related]
20. Body distribution of Lipiodol 131-J following intralymphatic radiotherapy. Fava G; Roncoroni L Nucl Med (Stuttg); 1965 Dec; 5(1):1-11. PubMed ID: 4287956 [No Abstract] [Full Text] [Related] [Next] [New Search]